6547.TWO
Price:
$37.75
Market Cap:
$12.41B
Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. The company is developing enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection; influenza vaccine, which has completed Phase III clinical trial to treat influenza; dengue vaccine, which has completed Phase II clinical trial for the treatment of dengue fever; respiratory cell fusion virus (RSV) antibody, which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19- severe special infectious pneumonia...[Read more]
Industry
Biotechnology
IPO Date
2015-09-16
Stock Exchange
TWO
Ticker
6547.TWO
According to Medigen Vaccine Biologics Corporation’s latest financial reports and current stock price. The company's current ROE is -4.45%. This represents a change of 296.87% compared to the average of -1.12% of the last 4 quarters.
The mean historical ROE of Medigen Vaccine Biologics Corporation over the last ten years is -18.02%. The current -4.45% ROE has changed -75.32% with respect to the historical average. Over the past ten years (40 quarters), 6547.TWO's ROE was at its highest in in the December 2021 quarter at 22.79%. The ROE was at its lowest in in the December 2023 quarter at -15.13%.
Average
-18.02%
Median
-22.18%
Minimum
-46.59%
Maximum
30.16%
Discovering the peaks and valleys of Medigen Vaccine Biologics Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.69%
Maximum Annual ROE = 30.16%
Minimum Annual Increase = -237.17%
Minimum Annual ROE = -46.59%
| Year | ROE | Change |
|---|---|---|
| 2024 | -2.09% | -93.07% |
| 2023 | -30.15% | 0.99% |
| 2022 | -29.86% | -198.99% |
| 2021 | 30.16% | -237.17% |
| 2020 | -21.99% | -52.81% |
| 2019 | -46.59% | 57.69% |
| 2018 | -29.55% | 32.08% |
| 2017 | -22.37% | 56.86% |
| 2016 | -14.26% | 5.50% |
| 2015 | -13.52% | 38.35% |
The current ROE of Medigen Vaccine Biologics Corporation (6547.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-20.70%
5-year avg
-10.79%
10-year avg
-18.02%
Medigen Vaccine Biologics Corporation’s ROE is greater than AP Biosciences Inc (-25.56%), less than PharmaEngine, Inc. (32.91%), greater than Adimmune Corporation (-10.32%), greater than Acepodia, Inc. (-11.14%), greater than Tanvex BioPharma, Inc. (-31.36%), greater than Foresee Pharmaceuticals Co., Ltd. (-98.79%), less than Ever Supreme Bio Technology Co., Ltd (37.36%), less than TaiDoc Technology Corporation (16.48%), less than TaiDoc Technology Corporation (16.48%), greater than CHO Pharma, Inc. (-8.57%),
| Company | ROE | Market cap |
|---|---|---|
| -25.56% | $13.62B | |
| 32.91% | $10.34B | |
| -10.32% | $8.22B | |
| -11.14% | $8.98B | |
| -31.36% | $16.23B | |
| -98.79% | $12.39B | |
| 37.36% | $14.45B | |
| 16.48% | $11.64B | |
| 16.48% | $11.64B | |
| -8.57% | $6.10B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigen Vaccine Biologics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medigen Vaccine Biologics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Medigen Vaccine Biologics Corporation's ROE?
How is the ROE calculated for Medigen Vaccine Biologics Corporation (6547.TWO)?
What is the highest ROE for Medigen Vaccine Biologics Corporation (6547.TWO)?
What is the 3-year average ROE for Medigen Vaccine Biologics Corporation (6547.TWO)?
What is the 5-year average ROE for Medigen Vaccine Biologics Corporation (6547.TWO)?
How does the current ROE for Medigen Vaccine Biologics Corporation (6547.TWO) compare to its historical average?